Adjust Font Sizing:

New Clinical Trial

February 21st, 2020

If you are living with excessive daytime sleepiness because of narcolepsy with cataplexy, you may want to consider the SPARKLE 1501 Study that is being conducted by a pharmaceutical company.

What is the purpose of the Sparkle 1501 Study?
This clinical study is testing an investigational drug (TAK-994). The main purpose of the study is to look at how safe and tolerable the investigational drug is and how it may affect a person’s narcolepsy symptoms.

Study participation eligibility
You may qualify if you:
– Are 18–65 years old
– Have been diagnosed with narcolepsy with cataplexy
– Meet additional requirements as determined by a screening process

Travel support and compensation for study participation may be available. A study doctor and staff can explain to you in greater detail other requirements and eligibility criteria you would have to meet in order to participate in the study.

To learn more about the Sparkle 1501 Study and to see if you may qualify, visit See this brochure for more information.

# # #
Date Created: February 21st, 2020
Last Updated: February 21st, 2020

Do NOT follow this link or you will be banned from the site!